Accurate Wealth Management LLC Purchases 365 Shares of CVS Health Co. (NYSE:CVS)

Accurate Wealth Management LLC grew its position in CVS Health Co. (NYSE:CVS – Get Rating) by 8.5% in the fourth quarter, according to its most recent filing with the SEC. The fund owned 4,657 shares of the pharmacy operator’s stock after acquiring an additional 365 shares during the period. Accurate Wealth Management LLC’s holdings in CVS Health were worth $422,000 as of its most recent filing with the SEC.

Other large investors also recently modified their holdings of the company. SRS Capital Advisors Inc. lifted its stake in shares of CVS Health by 105.8% in the 3rd quarter. SRS Capital Advisors Inc. now owns 284 shares of the pharmacy operator’s stock valued at $27,000 after acquiring an additional 146 shares during the last quarter. Karp Capital Management Corp acquired a new stake in CVS Health in the third quarter valued at $30,000. EWG Elevate Inc. acquired a new stake in CVS Health in the fourth quarter valued at $32,000. Coston McIsaac & Partners acquired a new stake in CVS Health in the second quarter valued at $34,000. Finally, Moisand Fitzgerald Tamayo LLC increased its holdings in CVS Health by 63.6% in the third quarter. Moisand Fitzgerald Tamayo LLC now owns 368 shares of the pharmacy operator’s stock valued at $35,000 after purchasing an additional 143 shares during the period. 77.29% of the stock is currently owned by institutional investors.

Analyst Upgrades and Downgrades

A number of analysts recently weighed in on CVS shares. Barclays decreased their price objective on CVS Health from $118.00 to $110.00 and set an “overweight” rating for the company in a report on Thursday, February 9th. TheStreet upgraded CVS Health from a “c+” rating to a “b” rating in a research note on Friday, November 25th. Jefferies Financial Group raised their price target on shares of CVS Health from $130.00 to $143.00 and gave the company a “buy” rating in a research report on Thursday, February 9th. Wells Fargo & Company dropped their price target on shares of CVS Health from $106.00 to $101.00 and set an “equal weight” rating on the stock in a research report on Tuesday, January 3rd. Finally, StockNews.com began coverage on shares of CVS Health in a research report on Thursday. They issued a “buy” rating on the stock. Three investment analysts have rated the stock with a hold rating and fourteen have issued a buy rating to the stock. Based on data from MarketBeat, CVS Health has an average rating of “Moderate Buy” and an average price target of $119.65.

CVS Health Trading Down 1.9 %

Shares of CVS stock opened at $74.37 on Friday. The company has a 50 day moving average of $85.40 and a 200-day moving average of $93.00. The company has a quick ratio of 0.67, a current ratio of 0.94 and a debt-to-equity ratio of 0.71. CVS Health Co. has a 12-month low of $73.91 and a 12-month high of $109.69. The firm has a market cap of $95.50 billion, a P/E ratio of 23.84, a PEG ratio of 1.17 and a beta of 0.65.

CVS Health (NYSE:CVS – Get Rating) last issued its quarterly earnings results on Wednesday, February 8th. The pharmacy operator reported $1.99 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.92 by $0.07. CVS Health had a net margin of 1.29% and a return on equity of 15.75%. The company had revenue of $83.85 billion during the quarter, compared to analyst estimates of $76.37 billion. During the same quarter last year, the business posted $1.98 EPS. CVS Health’s quarterly revenue was up 9.5% compared to the same quarter last year. Sell-side analysts anticipate that CVS Health Co. will post 8.84 earnings per share for the current year.

CVS Health Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Monday, May 1st. Stockholders of record on Friday, April 21st will be given a dividend of $0.605 per share. The ex-dividend date is Thursday, April 20th. This represents a $2.42 dividend on an annualized basis and a dividend yield of 3.25%. CVS Health’s dividend payout ratio (DPR) is currently 77.56%.

About CVS Health

(Get Rating)

CVS Health Corp. is a health solutions company, which engages in the provision of healthcare services. It operates through the following segments: Pharmacy Services, Retail or Long-Term Care, Health Care Benefits, and Corporate and Other. The Pharmacy Services segment focuses on the pharmacy benefit management solutions.